Liv Bona Dea Hospital Baku
| アゼルバイジャン | トルコ | オーストリア | |
| 骨髄移植術 | - | から $36,000 | から $140,000 |
| 非血縁者間同種骨髄移植術 | - | から $80,000 | から $180,000 |
| 選択的アフェレーシス | - | から $1,550 | - |
| 血漿交換術 | - | から $1,200 | から $2,000 |
| 血漿交換 | - | から $3,900 | - |
Bookimedは血液腫瘍科治療価格に追加料金を加算しません。料金はクリニックの公式価格表から来ています。国に到着時にクリニックで治療代を直接お支払いいただきます。
Bookimedはお客様の安全に取り組んでいます。血液腫瘍科治療で高い国際基準を維持し、世界中の国際患者サービスに必要なライセンスを有する医療機関とのみ協力しています。
Bookimedは無料専門サポートを提供します。専属医療コーディネーターが治療前、治療中、治療後にサポートし、あらゆる問題を解決します。血液腫瘍科治療の旅路でお一人になることはありません。
Dr. Selime Aydogdu is a specialist in pediatric hematology and oncology. She is known for her work in improving early cancer detection in children. Dr. Aydogdu has given many presentations and led discussions on recognizing early cancer symptoms. Her efforts have raised awareness in her field.
Her work has helped achieve better diagnostic results and higher survival rates for children. Dr. Aydogdu is dedicated to education and advocacy. She is a respected member of the pediatric oncology community.
アゼルバイジャンで血液疾患および腫瘍疾患の治療を受けている患者は、脱毛や疲労などの短期的な副作用を経験する可能性があります。長期的なリスクとしては、末梢神経障害や認知機能障害などが挙げられます。バクーのリブ・ボナ・デア病院や国立腫瘍センターなどの認定施設では、これらの問題に対処するための多職種連携による支援を提供しています。
Bookimedの専門家の意見：バクー・リブ・ボナ病院は年間20万人の患者を治療しており、2019年にはBookimedによって血液疾患とがん治療における最優秀病院として認められました。この高い患者数により、セリム・アイドグドゥ医師やトゥラル・パシャエフ医師といった専門医は、白血病や骨髄腫などの複雑な疾患に対する支持療法プロトコルを洗練させています。毒性物質の治療を受ける際には、国際的な安全基準への準拠を確保するため、バクーではJCI認証を受けた医療施設を優先的に利用すべきです。
患者からのフィードバック：患者は、疲労感が予想以上にひどく、休息だけでは容易に解消されないことが多いと指摘しています。また、神経障害や記憶障害は治療終了後も長く続く可能性があるため、これらのリスクについてはできるだけ早い段階で話し合うことが重要だと強調しています。
Liv Bona Dea Hospital Baku and the National Center of Oncology are the leading facilities for haematology-oncology in Azerbaijan. These centres provide JCI-accredited care and integrated diagnostic laboratories. They specialise in treating blood cancers like leukaemia and lymphoma using immunotherapy and bone marrow transplantation.
Bookimed Expert Insight: Data shows Liv Bona Dea Hospital Baku consistently ranks as a top choice. While the National Center of Oncology has more beds, Liv Bona Dea prioritises shorter waiting times. This makes them more accessible for those travelling from abroad for urgent chemotherapy or biopsies.
Patient Consensus: Patients in Azerbaijan value hospitals that combine pathology, chemotherapy, and transfusion services. They often note that having specialist haematologists ensures clearer diagnostic staging and transparent treatment options.
Azerbaijan provides oncological care featuring bone marrow transplantation, immunotherapy, and targeted molecular therapies. JCI-accredited facilities in Baku, such as Liv Bona Dea Hospital Baku, use global protocols. Treatments include TrueBeam radiotherapy, HIPEC for abdominal cancers, and precision medicine for complex blood disorders.
Bookimed Expert Insight: Liv Bona Dea Hospital Baku serves over 200,000 patients annually. It holds specific 2019 rankings for excellence in cancer and blood disorders. This high patient volume allows the facility to maintain 219 beds and 20 specialised departments. Australian patients can expect care that includes genetic tumour profiling and molecular testing.
Patient Consensus: Patients suggest confirming local diagnostic capacity and requesting English medical reports before travel. Experience shows that Baku facilities effectively coordinate complex multi-cycle regimens. They also provide dedicated international service desks.
Recommended haematologist-oncologists in Baku for international consultations include Dr Tural Pashayev and Dr Selime Aydogdu. They practise at the JCI-accredited Liv Bona Dea Hospital. These specialists provide care for adult and paediatric blood disorders. They use modern protocols for bone marrow transplants and cell therapy.
Bookimed Expert Insight: Baku has become a regional hub for haematology-oncology. Liv Bona Dea Hospital serves over 200,000 patients annually. In 2019, it received top rankings for blood disorder treatment. This high patient volume often means the medical teams have extensive experience. They handle complex cases like bone marrow failure and rare metabolic blood diseases.
Patient Consensus: Patients find the international support teams in Azerbaijan helpful. They appreciate that major facilities coordinate digital scan uploads. These teams also handle translations for overseas medical records.
Azerbaijan provides specialised treatment for blood disorders through dedicated centres and specialist clinics in Baku. Facilities like Liv Bona Dea Hospital Baku offer bone marrow transplantation, factor therapy, and iron chelation. The country manages these conditions through national healthcare programmes and regional haematology networks.
Bookimed Expert Insight: Liv Bona Dea Hospital Baku stands out for international patients. It holds JCI accreditation. Bookimed patients ranked it as a top centre for blood disorder treatment. Public centres handle high local volume. However, this private facility integrates Turkish Medical Association standards. This makes it a preferred choice for those seeking private rooms.
Patient Consensus: Patients recommend verifying that hospitals have dedicated haematology services before travel. Those managing rare disorders emphasise confirming access to clotting factors. They also suggest coordinating care with tertiary centres in Baku.
Medical tourism for oncology in Baku is a rapidly growing regional sector. The city is a hub for haematology-oncology. It serves many patients from Central Asia and the CIS. Facilities like Liv Bona Dea Hospital Baku use Turkish medical partnerships and maintain JCI-accredited standards.
Bookimed Expert Insight: Baku has transitioned from a patient source to a regional treatment destination. Liv Bona Dea Hospital Baku now treats 200,000 patients annually across 20 departments. This volume allows the facility to provide diverse specialisations within a single centre. These range from adult haematology to paediatric cell therapy.
Patient Consensus: Patients value having access to Turkish clinical protocols in Azerbaijan. Large private hospitals in Baku are praised for their multidisciplinary approach to blood disorders and complex cancers.